 A few weeks ago, I released two videos on the general effectiveness of chemotherapy. What happens when you add fasting to the mix? This is the first of three video series exploring that very question. For the past 50 years, chemotherapy has been a major medical treatment for a wide range of cancers. Its main strategy has been largely based on targeting cancer cells by means of DNA damage caused in part by the production of free radicals. Both of these drugs were first believed to be quite selective for tumor cells. We now know that normal cells also experience severe chemotherapy-dependent damage, leading to dose-limiting side effects, including bone marrow and immune system suppression, fatigue, vomiting, diarrhea, and in some cases, even death. If you do survive the DNA damage to normal cells, it can even lead to new cancers down the road. There are cell-protecting drugs that have been tried to reduce the side effects so you can pump in higher chemo-doses, but these drugs have not been shown to increase survival, in part because they may also be protecting the cancer cells. What about instead using fasting for cellular protection during cancer treatment? Fasting may have an unrecognized role in cancer prevention and treatment. Short-term fasting before and immediately after chemotherapy may minimize side effects, while at the same time actually make cancer cells more sensitive to treatment. That's exciting. During nutrient deprivation, healthy cells switch from growth to maintenance and repair, but tumor cells are unable to slow down their unbottled growth due to growth-promoting mutations that led them to become cancer cells in the first place. This inability to adapt to starvation may represent an important Achilles heel for many types of cancer cells. As a consequence of these differential responses of healthy versus cancer cells to short-term fasting, chemotherapy causes more DNA-damaging cells suicide in tumor cells while potentially leaving healthy cells unharmed. Thus, short-term fasting may protect healthy cells against the toxic properties of chemotherapy and render tumor cells more sensitive. More or less, that's the theory. Let's test it out. Tersenkinase inhibitors, a group of chemo-drugs that are now the mainstay of treatment in many types of cancer, let's see them in action. These are Petri dishes filled with cancer cells that have been dyed pink. Two types of lung cancer cells and one type of colorectal cancer. This is the before and this the after, exposed to the chemo-drugs or lotinib, gefitinib, chrysotinib, and regrafinib. See how there's less pink? That shows how many cancer cells the chemo killed off. Some of the cells for 24 hours first, though, and the drugs work even better. Even the starvation alone without the drugs killed off a bunch of them. The researchers conclude that these TKI drugs that are commonly administrated for treating solid tumors become potentiated in their activity by 24 hours of starvation. But that's an Petri dish. Similar results were found for breast cancer in a chemo-drug called doxorubicin. Here's five days of unhindered growth of breast cancer in a Petri dish from 150,000 cancer cells to 800,000 in under a week. Dripping on a little chemo can knock it down to around 600,000, but starve those cells for 48 hours first and the chemo can completely keep them in check. Even the short-term starvation alone can restrain growth. Short-term fasting raises the possibility that you could get twice the effect for half the dose, which may be particularly important for a drug as toxic as doxorubicin, which causes heart failure and as many as 1 in 3 at higher doses. Again, though, these are just in-vitro studies in a Petri dish. Then researchers moved to mice and found the same dual benefit, less toxic chemo, yet at the same time more effective, and not just by a little, a high enough chemo dose to kill 100% in less than a week, but after being starved for 60 hours after the same dose, 100% survived. Oh, okay, that's the toxicity. What about efficacy? Here's tumor growth without chemo, growth with chemo, and with chemo after short-term fasting, and this translated into improved survival. Interestingly, fasting alone appeared to work as well as the chemo and the same with radiation. Unbridled tumor growth knocked down by radiation therapy, and even more so after the combination of radiation and alternate-day fasting. But alternate-day fasting alone seemed to do as well as the radiation. Okay, but that's breast cancer in mice. I'm sure Mickey is thrilled for many, but what about in people? We'll explore that next.